Ciba Vision Raises Its Total Sales

CIBA Vision raised its total sales by 19 percent to 1,181 million Swiss francs (e787m-$652m) in the first 9 months of this year, but only by 9 percent in local currencies. The main growth factor was the launch of Visudyne, a breakthrough treatment for age-related macular degeneration, whose sales have ...

Keep reading this article by becoming a member


Enjoy unrestricted access to Eyewear Intelligence

To continue reading this article subscribe now

  • Unlimited access to our highly trusted industry insights and analysis
  • Benchmark yourself against the market and competitors
  • Find inspiration to drive your business forward
  • Stay up to date with new business models and startups

If you aren’t ready to subscribe now, you can REGISTER FOR FREE. Already an Eyewear Intelligence subscriber? Sign in here.